Drugs & Targets PIQUR receives EMA Orphan Drug designation for PQR309 in diffuse large B-cell lymphoma May 12, 2017Vol.43 No.19
Drugs & Targets Addario Institute, Biocept collaborate on liquid biopsy trial in lung cancer May 12, 2017Vol.43 No.19
Drugs & Targets EpiThany, Merck KGaA, Pfizer to evaluate combination of avelumab and EP-101 STEMVAC in breast cancer May 12, 2017Vol.43 No.19
Drugs & Targets Array BioPharma, Merck collaborate to study MEK inhibitor with Keytruda May 12, 2017Vol.43 No.19
Drugs & Targets OncoSec, Merck to evaluate ImmunoPulse IL-12 and Keytruda in metastatic melanoma May 12, 2017Vol.43 No.19
Drugs & Targets Regeneron, SillaJen to test combination treatment in kidney cancer May 12, 2017Vol.43 No.19
Drugs & Targets Regeneron, Inovio agree to study glioblastoma combination therapy May 12, 2017Vol.43 No.19
Drugs & Targets FDA grants an accelerated approval for AstraZeneca’s Imfinzi for urothelial carcinoma May 05, 2017Vol.43 No.18
Drugs & Targets Draft Local Coverage Determination favorable to Oncotype DX Genomic Prostate Score May 05, 2017Vol.43 No.18
Drugs & Targets Opdivo gets European approval for squamous cell head and neck cancer May 05, 2017Vol.43 No.18
